What This Drug News Could Mean for Sanofi Shareholders

What This Drug News Could Mean for Sanofi Shareholders

Submitted by admin on January 8, 2023 - 10:13pm
Source: 
Motley Fool
News Tags: 
Sanofi
Dupixent
Headline: 
What This Drug News Could Mean for Sanofi Shareholders
snippet: 
  • Dupixent could soon gain access to tens of thousands of patients.
  • If approved, it could produce $600 million in annual sales for Sanofi to split with Regeneron.
  • Sanofi offers investors a mix of income, growth, and value.

Do Not Allow Advertisers to Use My Personal information